Compass Therapeutics (CMPX) Change in Acquisitions & Divestments (2022 - 2026)

Compass Therapeutics has disclosed Change in Acquisitions & Divestments across 5 years of filings, most recently posting $83.3 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $83.3 million, up 128.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $148.2 million (up 10.87% YoY), and the FY2025 annual result was $101.3 million, down 24.97% from the prior year.
• Change in Acquisitions & Divestments came in at $83.3 million for Q1 2026 at Compass Therapeutics, up from $24.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $83.3 million in Q1 2026 to a low of $12.8 million in Q3 2022.
• The 5-year median for Change in Acquisitions & Divestments is $36.2 million (2022), against an average of $36.7 million.
• Across the five-year window, Change in Acquisitions & Divestments soared 169.86% in 2023 and tumbled 59.52% in 2025, its largest moves.
• Compass Therapeutics' Change in Acquisitions & Divestments stood at $36.2 million in 2022, then jumped by 42.01% to $51.4 million in 2023, then tumbled by 50.91% to $25.2 million in 2024, then declined by 4.49% to $24.1 million in 2025, then surged by 245.79% to $83.3 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $83.3 million (Q1 2026), $24.1 million (Q4 2025), and $13.9 million (Q3 2025), per Business Quant data.